Rethinking Today's ePRO Delivery For Tomorrow's Clinical Trials

The clinical trial landscape is evolving, but is eCOA/ePRO keeping pace? Willie Muehlhausen, Co-CEO & Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery should adapt to better serve modern trials. They identify barriers that are currently holding the industry back and explore the impact of overcoming these obstacles for all stakeholders.

Watch this on-demand conversation to learn why rapid build times can bring paper protocols to life, ensuring eCOA design meets study objectives. Discover how to navigate licensing and other operational challenges to ensure a smooth project launch. Finally, understand the benefits of a strategic shift that prioritizes speed of delivery and data quality.